Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity
about
Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variabilityBile acid transporters in health and diseaseBile acid transportersThe Concise Guide to PHARMACOLOGY 2013/14: transporters.Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites.Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).Heterogeneous accumulation of fluorescent bile acids in primary rat hepatocytes does not correlate with their homogenous expression of ntcp.Age-related changes in the hepatic pharmacology and toxicology of paracetamol.Clinical implications of changes in hepatic drug metabolism in older peopleDrug metabolism and ageing.Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.Structure-activity relationship for FDA approved drugs as inhibitors of the human sodium taurocholate cotransporting polypeptide (NTCP)Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2The role of transporters in the pharmacokinetics of orally administered drugs.Bile Acid Uptake Transporters as Targets for Therapy.
P2860
Q24596022-CE3EF474-8DFE-4D1F-8C29-2C6C9D7C5B59Q24647024-666BCCB2-F554-4149-B4BF-F43BFFF119D3Q24652624-D2C2FF22-7CBD-4F86-A9D7-0C0843F67A89Q30486743-9E68ABEF-FAEF-40A8-A8E4-13696CC0AC5BQ33883305-4007DDA8-271E-4406-8A9F-CDEE09576674Q34382931-65EDE5A3-ADAB-45F6-8356-3C91F15D40EDQ34603829-4E3CDF44-D1F0-42C8-929F-ABF128B6DA17Q34693445-9EC5BA83-4D24-480E-9853-A3AB92904F43Q35087112-05CD8634-DACF-4328-A736-DDA6FD6F9F81Q35101500-BB119F4C-6AEA-47F2-AD08-27B65D4B7248Q35166691-2B6AC49A-9822-42FA-BB6C-95A9B7E5D7EEQ35747971-3BBB14C4-AB2B-46BC-B475-439BA4CF3922Q36311265-95C3E88B-14F6-46E7-8136-CF2E23855268Q36742673-76A64886-540B-49E2-81AC-616D062E9748Q37207831-8F001020-860A-4226-AB74-DE20A67C87C4Q37537018-DFDA7D30-949E-42D3-ADDD-901F62DBF98CQ39156569-DA4F7939-BCAC-428F-8B71-8EA4E1006B72
P2860
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Modulation by drugs of human h ...... sporting polypeptide) activity
@ast
Modulation by drugs of human h ...... sporting polypeptide) activity
@en
Modulation by drugs of human h ...... sporting polypeptide) activity
@nl
type
label
Modulation by drugs of human h ...... sporting polypeptide) activity
@ast
Modulation by drugs of human h ...... sporting polypeptide) activity
@en
Modulation by drugs of human h ...... sporting polypeptide) activity
@nl
prefLabel
Modulation by drugs of human h ...... sporting polypeptide) activity
@ast
Modulation by drugs of human h ...... sporting polypeptide) activity
@en
Modulation by drugs of human h ...... sporting polypeptide) activity
@nl
P2093
P1476
Modulation by drugs of human h ...... sporting polypeptide) activity
@en
P2093
Cvetkovic M
Wilkinson GR
P304
P407
P577
1999-12-01T00:00:00Z